Annual Financials for Global Medical REIT Inc.
Assets
Fiscal year is January-December. All values USD millions. |
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
Cash & Short Term Investments |
6.6M | 10.6M | 15.57M | 18.72M | 22.29M | |
Cash Only |
6.6M | 10.6M | 15.57M | 18.72M | 22.29M | |
Total Short-Term Investments |
- | - | - | - | - | |
Cash & Short Term Investments Growth |
- | 60.76% | 46.86% | 20.21% | 19.09% | |
Short-Term Receivables |
11.61M | 19.21M | 25.89M | 31.59M | 37.71M | |
Short Term Receivables Growth |
- | 65.46% | 34.77% | 22.01% | 19.37% | |
Investment Securities |
- | - | - | - | - | |
Investment Securities Growth |
- | - | - | - | - | |
Securities in Custody |
- | - | - | - | - | |
Custody Securities Growth |
- | - | - | - | - | |
Other Investments |
- | 2.19M | - | 1.24M | 34.71M | |
Net Property, Plant & Equipment |
- | 3.08M | 3.6M | 3.81M | 3.48M | |
Other Assets (Including Intangibles) |
968,000 | 824,000 | 7.4M | 8.39M | 9.12M | |
Other Assets |
968,000 | 824,000 | 1.5M | 2.48M | 3.22M | |
Intangible Assets |
- | - | 5.9M | 5.9M | 5.9M | |
Total Assets |
636.1M | 884.93M | 1.1B | 1.26B | 1.39B | |
Total Assets Growth |
- | 39.12% | 24.41% | 14.77% | 10.27% | |
Return On Average Assets |
- | - | - | - | 1.44% | NA |
Liabilities & Shareholders' Equity
|
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
Total Debt |
317.04M | 389.33M | 594.8M | 584.34M | 704.65M | |
ST Debt & Current Portion LT Debt |
136,000 | 7.22M | 8.01M | 1.11M | 1.16M | |
Short Term Debt |
- | - | - | - | - | |
Current Portion of Long Term Debt |
136,000 | 7.22M | 8.01M | 1.11M | 1.16M | |
Long-Term Debt |
316.9M | 382.11M | 586.79M | 583.23M | 703.49M | |
LT Debt excl. Capitalized Leases |
314.87M | 378.95M | 578.57M | 570.62M | 692.96M | |
Capitalized Lease Obligations |
- | - | - | - | - | |
Total Debt Growth |
- | 22.80% | 52.77% | -1.76% | 20.59% | |
Total Debt / Total Assets |
49.84% | 44.00% | 54.03% | 46.25% | 50.58% | |
Deferred Taxes |
- | - | - | - | - | |
Other Liabilities |
19.31M | 35.25M | 48.35M | 41.57M | 39.54M | |
Other Liabilities (excl. Deferred Income) |
19.31M | 35.25M | 48.35M | 38.34M | 35.1M | |
Total Liabilities |
336.35M | 424.58M | 643.15M | 625.91M | 744.2M | |
Total Liabilities Growth |
- | 26.23% | 51.48% | -2.68% | 18.90% | |
Preferred Stock (Carrying Value) |
74.96M | 74.96M | 74.96M | 74.96M | 74.96M | |
Redeemable Preferred Stock |
- | - | - | - | - | |
Non-Redeemable Preferred Stock |
74.96M | 74.96M | 74.96M | 74.96M | 74.96M | |
Common Equity (Total) |
194.34M | 355.31M | 369.85M | 547.83M | 558.03M | |
Common Stock Par/Carry Value |
26,000 | 44,000 | 49,000 | 65,000 | 66,000 | |
Additional Paid-In Capital/Capital Surplus |
243.04M | 433.33M | 504.79M | 711.41M | 721.99M | |
Retained Earnings |
(45.01M) | (71.39M) | (116.77M) | (157.02M) | (198.71M) | |
ESOP Debt Guarantee |
- | - | - | - | - | |
Cumulative Translation Adjustment/Unrealized For. Exch. Gain |
- | - | - | - | - | |
Unrealized Gain/Loss Marketable Securities |
- | - | - | - | - | |
Revaluation Reserves |
- | - | - | - | - | |
Other Appropriated Reserves |
- | - | - | - | - | |
Unappropriated Reserves |
- | - | - | - | - | |
Treasury Stock |
- | - | - | - | - | |
Common Equity / Total Assets |
30.55% | 40.15% | 33.59% | 43.36% | 40.05% | |
Total Shareholders' Equity |
269.3M | 430.27M | 444.81M | 622.79M | 632.98M | |
Total Shareholders' Equity / Total Assets |
42.34% | 48.62% | 40.40% | 49.29% | 45.43% | |
Return On Average Total Equity |
- | - | - | - | 3.05% | NA |
Accumulated Minority Interest |
30.46M | 30.08M | 12.96M | 14.79M | 16.08M | |
Total Equity |
299.75M | 460.35M | 457.76M | 637.58M | 649.07M | |
Liabilities & Shareholders' Equity |
636.1M | 884.93M | 1.1B | 1.26B | 1.39B | |